1,260
Views
7
CrossRef citations to date
0
Altmetric
Influenza – Research Paper

Evaluation of influenza vaccination coverage in Shanghai city during the 2016/17 to 2020/21 influenza seasons

, , , , &
Article: 2075211 | Received 23 Feb 2022, Accepted 05 May 2022, Published online: 27 May 2022

ABSTRACT

Influenza is a common infectious disease resulting in substantial morbidity and mortality globally. The most effective strategy for preventing influenza is annual vaccination; however, the coverage rate of the influenza vaccine in Shanghai has not been well explored or reported. Therefore, this study aimed to determine coverage with the influenza vaccine and access trends in Shanghai city; data from Shanghai immunization information system was analyzed to estimate vaccination coverage during 2016–2017 through 2020–2021 influenza seasons. Vaccination coverage by age groups, immigration status, and districts was accessed. The influenza vaccination coverage (at least one dose) for 2016/2017 to 2020/2021 influenza seasons was 10.8‰ (95‰ CI: 10.7–10.8), 12.3‰ (95‰ CI: 12.3–12.4), 10.1‰ (95‰ CI: 10.0–10.1), 20.1‰ (95‰ CI: 20.0–20.2) and 50.8‰ (95‰ CI: 50.7–50.8) respectively. Although we found significantly higher vaccination coverage in females, children from 6 months to 17 years, and residents, it is still low in all subgroups of the population in Shanghai. Therefore, taking effective steps to promote influenza vaccination in Shanghai is recommended.

Introduction

Influenza is a group illnesses that range in severity, and can lead to hospitalization and death.Citation1,Citation2 The World Health Organization (WHO) estimates that 3,000,000–5,000,000 severe cases and 290,000–650,000 respiratory disease-related deaths occur annually.Citation3,Citation4 In China, human influenza viruses were associated with an average of 2.5 excess influenza-like-illness (ILI) consultations per 1000 person-years in 30 provinces each year from 2006 to 2015; this had a considerable impact on population morbidity, with a consequent healthcare and economic burden.Citation5

Several studiesCitation6–8 and long-term practices in many countries have shown that influenza vaccination is the most effective way to prevent influenza; the vaccine significantly reduces the risk of influenza and associated serious complications. The WHO and the Chinese Centers for Disease Control and Prevention have recommended that individuals without contraindications aged ≥6 months should get seasonal influenza vaccination.Citation3,Citation9,Citation10

Currently, the influenza vaccine is not included in the National Immunization Program; therefore, it is optional and self-funded in China. The overall coverage rate of influenza vaccination is only 2–3‰,Citation11 which is well below the target recommended by the WHO. Some areas of China have implemented policies providing free influenza vaccinations to specific groups such as the elderly, medical workers, and students, which has significantly increased the vaccination coverage in the target population. Despite Shanghai being one of the world’s largest seaports and a major industrial and commercial center of China, no free vaccination programs have been implemented. People can get the “current year” influenza vaccines from September to April of the following year in immunization clinics at their own expense. The coverage rate of the influenza vaccination in Shanghai has yet to be reported. Therefore, determining the influenza vaccination coverage would be useful for immunization programs targeting interventions and help to improve the full influenza vaccination coverage. This study aimed to quantify the influenza vaccination coverage from 2016/2017 to 2020/2021, overall, and stratified by gender, age, immigration status, and districts.

Methods

Data source

Data on influenza vaccinations were obtained from the Shanghai immunization information system, which contains vaccination data for all citizens living in Shanghai. Demographic information (such as gender, date of birth, address, and immigration status) as well as vaccination type and data were retrieved from this database. Population data used in this study were obtained from the Shanghai statistics yearbooks of 2016–2020. The main indicators used include the population by age, districts, and immigration status. Anonymized individual records of the target population were extracted from the Shanghai immunization information system. Data were encrypted and stored in specific computers, and all researchers signed confidentiality agreements. Immigration status of participants was classified as resident and migrant in this study. Migrant population included population from other provinces or from abroad.

Statistical analysis

Data were organized and analyzed by Microsoft Excel 2020 and SPSS 17.0 (SPSS Inc, Chicago, IL, USA) software. Using the influenza vaccination population and the total population in Shanghai from 2016 to 2020, the influenza vaccination coverage (at least one dose) was estimated. The coverage rates of influenza vaccination during different influenza seasons to 50.8‰ were calculated separately, in addition to the 95‰ confidence intervals (95‰ CI) during each period. The 95‰ confidence intervals were calculated using SPSS software (version 17.0), using the following equation: (p-Zα/2Sp, p+Zα/2Sp), where Zα/2 = 1.96 and Sp is the standard deviation. The influenza vaccination coverage was estimated among strata defined by gender, age, immigration status, and district. Tests for linear trends across periods (2016/2017 to 2020/2021) were performed using a weighted linear regression on the season-specific estimates, using season number as the independent variable and the inverse of the estimated variance of the influenza vaccination coverage as the weights. We adopted the χ2 test to examine whether the coverage of influenza vaccination was significantly different across the subgroups. A significance level of 0.05 was used.

Results

Overall coverage of influenza vaccinations

During the 2016/2017 through 2020/2021 influenza seasons, the number of people that received an influenza vaccination was 2,522,076 with an average of 504,415 vaccines per season. The total number of population in each influenza seasons were about 24.2 million, 24.2 million, 24.2 million, 24.3 million and 24.9 million respectively ().

Table 1. The number of individuals vaccinated against the seasonal influenza and its percentage over the total target population (in brackets) in Shanghai city during the 2016/2017 through to the 2020/2021 influenza seasons.

The influenza vaccination coverage (at least one dose) for the 2016/2017 to 2020/2021 influenza seasons was 10.8‰ (95‰ CI: 10.7–10.8), 12.3‰ (95‰ CI: 12.3–12.4), 10.1‰ (95‰ CI: 10.0–10.1), 20.1‰ (95‰ CI: 20.0–20.2), and 50.8‰ (95‰ CI: 50.7–50.9), respectively. The coverage increased from 10.8‰ in the 2016/2017 influenza season to 50.8‰ in the 2019/2020 influenza season, and the average annual increase was 0.805 (p < 0.001) based on the slope of the trend test. The coverage increased from 2016/2017 to 2020/2021 in both females and males, all age groups, and in both residents and migrants. We observed a significant increase in the coverage of influenza vaccination across the different districts. The coverage rate of influenza vaccination also increased year by year in each district. From 2016/2017 to 2020/2021, the total coverage of influenza vaccination in Jingan, Putuo, Hongkou, Yangpu, Baoshan, Songjiang, Qingpu, Fengxian and Chongming districts was lower than the average rate of Shanghai city ().

Table 2. Influenza vaccination coverage (‰) in of the target population and 95‰ confidence intervals for Shanghai city during the 2016/2017 through 2020/2021 influenza seasons. Trend over seasons is provided as slope (annual percent change) of linear trend analysis.

Influenza vaccination coverage across subgroups

The influenza vaccination coverage was 22.5‰ for females and 19.5‰ for males in the 2016–2020 influenza seasons. Influenza vaccination coverage among people aged 0.5–17 years, 18–59 years, and ≥60 years increased significantly from 93.9‰, 0.9‰ and 4.1‰, respectively, in the 2016/2017 influenza season to 30.98‰, 17.6‰ and 37.5‰, respectively, in the 2020/2021 influenza season. For all influenza seasons, the difference is in favor of the female gender and youngest age ().

The influenza vaccination coverage was 21.6‰ for residents and 19.7‰ for migrants from 2016/2017 to 2020/2021. There was a significant difference in influenza coverage between strata defined by immigration status. The coverage rate of residents in 2016/2017 and 2017/2018 was lower than of the migrants, while the coverage rate of residents in 2018/2019, 2019/2020, and 2020/2021 was higher than of migrants ().

Discussion

The disease burden of seasonal influenza is still heavy in China, and the influenza vaccination is one of the most effective measures to prevent influenza.Citation12,Citation13 Influenza vaccines protect people from infection and reduce the spread, benefiting those who do not have access to vaccination.Citation14 However, the influenza vaccine is not included in the National Immunization Program in China.Citation15 And people have to pay to vaccinate themselves. To the best of our knowledge, no data concerning influenza vaccination coverage among the whole population in Shanghai have been published. Quantifying the influenza vaccination coverage in recent years could help guide public health action to improve full influenza vaccination coverage. Therefore, the goal of this study was to investigate the influenza vaccination coverage in Shanghai from the 2016/2017 to 2020/2021 influenza seasons.

In this study, although the influenza vaccination coverage showed a growth trend in Shanghai city from the 2016/2017 to 2020/2021, it was still extremely low, between 10.8‰-50.8‰, which is not lower than the target rate recommended by the WHO and that of other high-income countries or even upper-middle-income countries.Citation16–20 One more data point demonstrating the low uptake of influenza vaccinations in China is that the influenza vaccine rate among the general population is only about 2.0‰.Citation21 As of 2014, over 100 countries worldwide already had influenza vaccination policies, with vaccination costs subsidized by the respective governments.Citation11 In contrast, only a handful of large cities in China provide free influenza vaccines for at least one of the high-risk groups.Citation22–26 Despite Shanghai being one of the most developed cities worldwide; it dose not provide reimbursement for the influenza vaccination. Our results demonstrate that an effective immune barrier is not being built and there is potential for localized influenza outbreaks. Therefore, we should prioritize strengthening the vaccination rate of influenza in Shanghai.

Studies indicated that appropriate policies may promote influenza vaccination coverage in the short term.Citation27 For instance, vaccination coverage was higher in workplaces with free vaccination policies than in those without a free vaccination policy. Furthermore, the coverage was higher when vaccination is mandatory or encouraged by the workplaces.

Although the influenza vaccination coverage is low in the different populations in Shanghai, we still observed an obvious difference across some sociodemographic factors, such as gender, age, immigration status and regional disparity. The influenza vaccination coverage across all age groups are well below the target set by the WHO, and we found that obvious difference was observed according to age group, with a higher coverage seen in the 0.5–17 years age group. In the 2020/2021 influenza season, to minimize the interference of influenza to the COVID-19 epidemic, Shanghai has increased the publicity and promotion of influenza vaccination among school-age children. As a result, the vaccination coverage for children aged 0.5–17 years was found to be 309.8‰ in the 2020/2021 influenza season, which is about three times than that of 2019/2020. We also found that vaccination coverage in females was significantly higher than that in males. The gender difference in influenza vaccination uptake be attributed to women being more aware of health issues and general well-being.Citation27

Immigrant status remained a determinant of the influenza vaccination coverage. The influenza vaccination coverage among residents was found to be significantly higher than among migrants, which may be due to residents being more financially capable and having a higher awareness of influenza. A cross-sectional study shown that influenza vaccine coverage among migrants in Shanghai in the 2019/2020 and early 2020/2021 influenza seasons were 26.3‰ and 24.4‰ respectively.Citation28 The result was considerable different from that of our study. The reasons for the differences were as following. First, the estimates of influenza vaccination coverage in their study were based on self-reported information, which may be prone to recall bias. Second, their study used purposive sampling which may led to a selection bias, as the sampling was not random, and their sample size was small.

There are several limitations to this study. First, our data may have slightly underestimated the vaccination rate because not all vaccinations against influenza were reported; some people may not have received the influenza vaccine in Shanghai, so we cannot synchronize their vaccination records. Second, we did not evaluate the receipt of two doses of influenza vaccine.

In summary, we quantitatively reported the influenza vaccination coverage of different population in Shanghai for the first time. Despite the highly recommended influenza vaccine uptake worldwide, our study found that the seasonal influenza vaccination rate was extremely low in Shanghai; therefore, it is necessary to take implement effective strategies to promote influenza vaccination in Shanghai as soon as possible.

Ethics considerations

Anonymized individual records of population were extracted from the Shanghai immunization information system. This study was approved by the ethical review board of Shanghai Municipal Center for Disease Control and Prevention.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

This study was supported by Research on Assessment of Respiratory virus vaccines Effectiveness Based on Sentinel Surveillance Grands from Shanghai Municipal Health Commission [GWV-10.2-YQ41] and the Study on the Seroepidemiology and Transmission Risk of COVID-19 Grants from the Science and Technology Commission of Shanghai Municipality, China [Number:20JC1410200].

References

  • Yamauchi Y. Influenza a virus uncoating. Adv Virus Res. 2020;106:1–5. doi:10.1016/bs.aivir.2020.01.001.
  • Centers for Disease Control and Prevention. Key facts about influenza (flu); [accessed 2020 Dec 25]. https://www.cdc.gov/flu/about/keyfacts.htm.
  • Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza- associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–300. doi:10.1016/S0140-6736(17)33293-2.
  • World Health Organization. New global influenza strategy; [accessed 2021 Jan 10]. https://www.who.int/news/item/11-03-2019-who-launches-new-global-influenza-strategy.
  • Feng L, Feng S, Chen T, Yang J, Lau YC, Peng Z, Li L, Wang X, Wong JYT, Qin Y, et al. Burden of influenza-associated outpatient influenza-like illness consultations in China, 2006-2015: a population-based study. Influ Other Respir Viruses. 2020;14(2):162–72. doi:10.1111/irv.12711.
  • Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36–44. doi:10.1016/S1473-3099(11)70295-X.
  • Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev (3). 2004:CD001269. doi:10.1002/14651858.CD001269.pub2.
  • Xing Y, Liu M. Meta analysis on the effectiveness of inactivated influenza vaccine. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30:368–70.
  • National Immunization Advisory Committee (NIAC) Technical Working Group (TWG). Influenza vaccination TWG. Technical guidelines for seasonal influenza vaccination in China (2021-2022). Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(10):1722–49. doi:10.3760/cma.j.cn112338-20210913-00732.
  • Feng L, Yang P, Zhang T, Yang J, Fu C, Qin Y, Zhang Y, Ma C, Liu Z, Wang Q, et al. Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015). Hum Vaccin Immunother. 2015;11(8):2077–101. doi:10.1080/21645515.2015.1027470.
  • Peng ZB, Wang DY, Yang J, Yang P, Zhang YY, Chen J, Chen T, Zheng YM, Zheng JD, Jiang SQ, et al. Current situation and related policies on the implementation and promotion of influenza vaccination, in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(8):1045–50. doi:10.3760/cma.j.issn.0254-6450.2018.08.007.
  • Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, et al. Influenza-Associated excess respiratory mortality in China, 2010–15: a population-based study. Lancet Public Health. 2019;4(9):30163–E81. doi:10.1016/S2468-2667(19)30163-X.
  • Qi L, Li Q, Ding XB, Gao Y, Ling H, Liu T, Xiong Y, Su K, Tang WG, Feng LZ, et al. Mortality burden from seasonal influenza in Chongqing, China, 2012–2018. Hum Vaccin Immunother. 2020;16(7):1668–74. doi:10.1080/21645515.2019.1693721.
  • World Health Organization. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012;87(47):461–76. English, French. PMID: 23210147.
  • Loerbroks A, Stock C, Bosch JA, Litaker DG, Apfelbacher CJ. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health. 2012;22(4):562–68. doi:10.1093/eurpub/ckr094.
  • General Office of the State Council of People’s Republic of China. National regulation for vaccine distribution and administration; 2016 version [accessed 2021 Jan 10]. http://www.gov.cn/zhengce/content/2016-04/25/content_5067597.htm.
  • Ganczak M, Gil K, Korzeń M, Bażydło M. Coverage and influencing determinants of influenza vaccination in elderly patients in a country with a poor vaccination implementation. Int J Environ Res Public Health. 2017;14(6):665. doi:10.3390/ijerph14060665.
  • Spruijt IT, de Lange MMA, Dijkstra F, Donker GA, van der Hoek W. Long-Term correlation between influenza vaccination coverage and incidence of influenza-like illness in 14 European countries. PLoS One. 2016;11(9):e0163508. doi:10.1371/journal.pone.0163508.
  • Assaf AM, Hammad EA, Haddadin RN. Influenza vaccination coverage rates, knowledge, attitudes, and beliefs in Jordan: a comprehensive study. Viral Immunol. 2016;29(9):516–25. doi:10.1089/vim.2015.0135.
  • Cha SH, Paik JH, Lee MR, Yang H, Park SG, Jeon YJ, Yoo S. Influenza vaccination coverage rate according to the pulmonary function of Korean adults aged 40 years and over: analysis of the fifth Korean national health and nutrition examination survey. J KoreanMed Sci. 2016;31(5):709–14. doi:10.3346/jkms.2016.31.5.709.
  • Yang J, Atkins KE, Feng L, Pang M, Zheng Y, Liu X, Cowling BJ, Yu H. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. 2016;34(47):5724–35. doi:10.1016/j.vaccine.2016.10.013.
  • Lv M, Fang R, Wu J, Pang X, Deng Y, Lei T, Xie Z. The free vaccination policy of influenza in Beijing, China: the vaccine coverage and its associated factors. Vaccine. 2016;34(18):2135–40. doi:10.1016/j.vaccine.2016.02.032.
  • Government of Xinxiang County. Opin Influ Vacci; 2017 [accessed 2018 Apr 28]. http://www.xinxiang.gov.cn/sitegroup/root/html/ff80808122c050240122c5d7f2a5000c/20171115163030721.html.
  • Government of Guizhou Province. Vaccines Covered Med Ins; 2017 [accessed 2018 Apr 28]. http://www.gzgov.gov.cn/xxgk/jdhy/rdhy/201709/t20170929_1070481.html.
  • Government of Ningbo City. Vaccines Covered Med Ins; 2015 [accessed 2018 Apr 28]. http://nb.people.com.cn/n/2015/0114/c200864-23554533.html.
  • Feng L, Li Z. Analysis on immunization policy and key elements from countries with high influenza vaccination coverage. Chin Prev Med. 2019;53:968–72.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
  • Han K, Francis MR, Xia A, Zhang R, Hou Z. Influenza vaccination uptake and its determinants during the 2019-2020 and early 2020-2021 flu seasons among migrants in Shanghai, China: a cross-sectional survey. Hum Vaccin Immunother. 2022;18(1):1–8. doi:10.1080/21645515.2021.2016006.